Acute decompensated heart failure: Update on new and emerging evidence and directions for future research

Journal of Cardiac Failure

Volumn 19, Issue 6, 2013, Pages 371-389

  Givertz, Michael M ^a   Teerlink, John R ^b   Albert, Nancy M ^c   Westlake Canary, Cheryl A ^d   Collins, Sean P ^e   Colvin Adams, Monica ^f   Ezekowitz, Justin A ^g   Fang, James C ^h   Hernandez, Adrian F ⁱ   Katz, Stuart D ^j   Krishnamani, Rajan ^k   Stough, Wendy Gattis ^l   Walsh, Mary N ^m   Butler, Javed ⁿ   Carson, Peter E ^o   Dimarco, John P ^p   Hershberger, Ray E ^q   Rogers, Joseph G ⁱ   Spertus, John A ^r   Stevenson, William G ^a   Sweitzer, Nancy K ^s   Wilson Tang, W H ^c   Starling, Randall C ^c   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d AZUSA PACIFIC UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Advanced Cardiovascular Institute   (United States)

^l CAMPBELL UNIVERSITY   (United States)

^m Care Group   (United States)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o GEORGETOWN UNIVERSITY   (United States)

^p UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^q OHIO STATE UNIVERSITY   (United States)

^r UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^s UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

more..

Author keywords

biomarkers; clinical trials; diuretics; Heart failure; quality of care; ultrafiltration; vasodilators

Indexed keywords

ALISKIREN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; ENOXIMONE; FUROSEMIDE; GALECTIN 3; LEVOSIMENDAN; LOOP DIURETIC AGENT; MILRINONE; NATRIURETIC FACTOR; NESIRITIDE; NITRATE; OMECAMTIV MECARBIL; PIPERANOMETOZINE; PLACEBO; RELAXIN; ROLOFYLLINE; SERALAXIN; UNCLASSIFIED DRUG; URODILATIN;

ACUTE HEART FAILURE; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTINUOUS INFUSION; DRUG DOSE COMPARISON; DYSPNEA; EMERGENCY WARD; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH STATUS; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPOTENSION; KIDNEY DISEASE; MORBIDITY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEIZURE; TACHYCARDIA; THORAX PAIN; ULTRAFILTRATION; UNITED STATES;

EID: 84878588169     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.04.002     Document Type: Review

References (163)

1. G.M. Felker, K.F. Adams Jr., M.A. Konstam, C.M. O'Connor, and M. Gheorghiade The problem of decompensated heart failure: nomenclature, classification, and risk stratification Am Heart J 145 2003 S18 S25
2. J. Lindenfeld, N.M. Albert, J.P. Boehmer, S.P. Collins, J.A. Ezekowitz, and M.M. Givertz HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 194
3. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 90
4. M. Hall, S. Levant, and C. DeFrances Hospitalization for congestive heart failure: United States, 2000-2010 NCHS Data Brief 108 2012 1 8
5. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, and W.B. Borden Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 220
6. J. Chen, S.L. Normand, Y. Wang, and H.M. Krumholz National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 2011 1669 1678
7. P.A. Heidenreich, J.G. Trogdon, O.A. Khavjou, J. Butler, K. Dracup, and M.D. Ezekowitz Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 2011 933 944
8. M. Gheorghiade, M. Vaduganathan, G.C. Fonarow, and R.O. Bonow Rehospitalization for heart failure: problems and perspectives J Am Coll Cardiol 61 2013 391 403
9. C.M. O'Connor, R.C. Starling, A.F. Hernandez, P.W. Armstrong, K. Dickstein, and V. Hasselblad Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
10. G.C. Fonarow, W.T. Abraham, N.M. Albert, W. Gattis Stough, M. Gheorghiade, and B.H. Greenberg Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Arch Intern Med 167 2007 1493 1502
11. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.A. Gattis, M. Gheorghiade, and B. Greenberg Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): rationale and design Am Heart J 148 2004 43 51
12. F. Follath, M.B. Yilmaz, J.F. Delgado, J.T. Parissis, R. Porcher, and E. Gayat Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) Intensive Care Med 37 2011 619 626
13. S.I. Chaudhry, Y. Wang, J. Concato, T.M. Gill, and H.M. Krumholz Patterns of weight change preceding hospitalization for heart failure Circulation 116 2007 1549 1554
14. M.S. Nieminen, D. Brutsaert, K. Dickstein, H. Drexler, F. Follath, and V.P. Harjola EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736
15. S.P. Collins, C.J. Lindsell, A.B. Storrow, G.J. Fermann, P.D. Levy, and P.S. Pang Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: identifying patients who do not respond to standard therapy Heart Fail Rev 17 2012 387 394
16. A. Mebazaa, M. Gheorghiade, I.L. Pina, V.P. Harjola, S.M. Hollenberg, and F. Follath Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes Crit Care Med 36 2008 S129 S139
17. J.R. Teerlink, M. Metra, G.M. Felker, P. Ponikowski, A.A. Voors, and B.D. Weatherley Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study Lancet 373 2009 1429 1439
18. B.M. Massie, C.M. O'Connor, M. Metra, P. Ponikowski, J.R. Teerlink, and G. Cotter Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
19. G.J. Fermann, and S.P. Collins Observation units in the management of acute heart failure syndromes Curr Heart Fail Rep 7 2010 125 133
20. J.A. Ezekowitz, P. Kaul, J.A. Bakal, H. Quan, and F.A. McAlister Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail 13 2011 142 147
21. W.T. Abraham, P.B. Adamson, R.C. Bourge, M.F. Aaron, M.R. Costanzo, and L.W. Stevenson Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
22. M.R. Zile, T.D. Bennett, S.M. St John, Y.K. Cho, P.B. Adamson, and M.F. Aaron Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures Circulation 118 2008 1433 1441
23. R.S. Small, W. Wickemeyer, R. Germany, B. Hoppe, J. Andrulli, and P.A. Brady Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert J Card Fail 15 2009 475 481
24. S.D. Solomon, J. Dobson, S. Pocock, H. Skali, J.J. McMurray, and C.B. Granger Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure Circulation 116 2007 1482 1487
25. J.G. Cleland, K. Swedberg, F. Follath, M. Komajda, A. Cohen-Solal, and J.C. Aguilar The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 2003 442 463
26. M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, and A. Cohen-Solal The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 2003 464 474
27. K.F. Adams Jr., G.C. Fonarow, C.L. Emerman, T.H. LeJemtel, M.R. Costanzo, and W.T. Abraham Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
28. G.M. Felker, K.L. Lee, D.A. Bull, M.M. Redfield, L.W. Stevenson, and S.R. Goldsmith Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
29. J.T. Heywood, G.C. Fonarow, M.R. Costanzo, V.S. Mathur, J.R. Wigneswaran, and J. Wynne High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 2007 422 430
30. W.F. Peacock, M.R. Costanzo, T. De Marco, M. Lopatin, J. Wynne, and R.M. Mills Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry Cardiology 113 2009 12 19
31. V. Hasselblad, W. Gattis Stough, M.R. Shah, Y. Lokhnygina, C.M. O'Connor, and R.M. Califf Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial Eur J Heart Fail 9 2007 1064 1069
32. J. Butler, D.E. Forman, W.T. Abraham, S.S. Gottlieb, E. Loh, and B.M. Massie Relationship between heart failure treatment and development of worsening renal function among hospitalized patients Am Heart J 147 2004 331 338
33. M.B. Yilmaz, E. Gayat, R. Salem, J. Lassus, M. Nikolaou, and S. Laribi Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis Eur J Heart Fail 13 2011 1244 1252
34. J.M. Testani, J. Chen, B.D. McCauley, S.E. Kimmel, and R.P. Shannon Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival Circulation 122 2010 265 272
35. D.R. Salvador, N.R. Rey, G.C. Ramos, and F.E. Punzalan Continuous infusion versus bolus injection of loop diuretics in congestive heart failure Cochrane Database Syst Rev 2005 CD003178
36. S. Paterna, P. Di Pasquale, G. Parrinello, E. Fornaciari, G.F. Di, and S. Fasullo Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study J Am Coll Cardiol 45 2005 1997 2003
37. G. Licata, P. Di Pasquale, G. Parrinello, A. Cardinale, A. Scandurra, and G. Follone Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects Am Heart J 145 2003 459 466
38. S. Paterna, P. Di Pasquale, G. Parrinello, P. Amato, A. Cardinale, and G. Follone Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure Eur J Heart Fail 2 2000 305 313
39. S. Paterna, S. Fasullo, G. Parrinello, S. Cannizzaro, I. Basile, and G. Vitrano Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (class C) (SMAC-HF study) Am J Med Sci 342 2011 27 37
40. M.R. Costanzo, M.E. Guglin, M.T. Saltzberg, M.L. Jessup, B.A. Bart, and J.R. Teerlink Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 49 2007 675 683
41. M. Patarroyo, E. Wehbe, M. Hanna, D.O. Taylor, R.C. Starling, and S. Demirjian Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure J Am Coll Cardiol 60 2012 1906 1912
42. B.A. Bart, S.R. Goldsmith, K.L. Lee, M.M. Givertz, C.M. O'Connor, and D.A. Bull Ultrafiltration in decompensated heart failure with cardiorenal syndrome N Engl J Med 367 2012 2296 2304
43. VMAC Investigators Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
44. J.D. Sackner-Bernstein, H.A. Skopicki, and K.D. Aaronson Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 2005 1487 1491
45. J.D. Sackner-Bernstein, M. Kowalski, M. Fox, and K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
46. Scios. Panel of cardiology experts provides recommendations to Scios regarding NATRECOR. 2005. Available at: http://www sciosinc com/scios/pr- 1118721302.
47. T.C. Westfall, and D.P. Westfall Adrenergic agonists and antagonists L.L. Brunton, B. Chabner, B. Knollman, Goodman & Oilman's The Pharmacological Basis of Therapeutics l2th ed. 2011 McGraw-Hill New York 277 334
48. J.A. Kellum, and M. Decker Use of dopamine in acute renal failure: a meta-analysis Crit Care Med 29 2001 1526 1531
49. R. Bellomo, M. Chapman, S. Finfer, K. Hickling, J. Myburgh Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial Lancet 356 2000 2139 2143
50. U. Elkayam, T.M. Ng, P. Hatamizadeh, M. Janmohamed, and A. Mehra Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action Circulation 117 2008 200 205
51. G. Giamouzis, J. Butler, R.C. Starling, G. Karayannis, J. Nastas, and C. Parisis Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) trial J Card Fail 16 2010 922 930
52. S.S. Gottlieb, D.C. Brater, I. Thomas, E. Havranek, R. Bourge, and S. Goldman BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy Circulation 105 2002 1348 1353
53. V. Vallon, C. Miracle, and S. Thomson Adenosine and kidney function: potential implications in patients with heart failure Eur J Heart Fail 10 2008 176 187
54. M.T. Slawsky, and M.M. Givertz Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure Expert Opin Pharmacother 10 2009 311 322
55. G. Cotter, H.C. Dittrich, B.D. Weatherley, D.M. Bloomfield, C.M. O'Connor, and M. Metra The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment J Card Fail 14 2008 631 640
56. A.A. Voors, H.C. Dittrich, B.M. Massie, P. DeLucca, G.A. Mansoor, and M. Metra Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) J Am Coll Cardiol 57 2011 1899 1907
57. J.R. Teerlink, V.J. Iragui, J.P. Mohr, P.E. Carson, P.J. Hauptman, and D.H. Lovett The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT Drug Saf 35 2012 233 244
58. M.M. Givertz Adenosine A1 receptor antagonists at a fork in the road Circ Heart Fail 2 2009 519 522
59. S.L. Teichman, E. Unemori, J.R. Teerlink, G. Cotter, and M. Metra Relaxin: review of biology and potential role in treating heart failure Curr Heart Fail Rep 7 2010 75 82
60. X.J. Du, R.A. Bathgate, C.S. Samuel, A.M. Dart, and R.J. Summers Cardiovascular effects of relaxin: from basic science to clinical therapy Nat Rev Cardiol 7 2010 48 58
61. J.R. Teerlink, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, and B.H. Greenberg Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 381 2013 29 39
62. M.S. Cuffe, R.M. Califf, K.F. Adams Jr., R. Benza, R. Bourge, and W.S. Colucci Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
63. A. Mebazaa, M.S. Nieminen, M. Packer, A. Cohen-Solal, F.X. Kleber, and S.J. Pocock Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial JAMA 297 2007 1883 1891
64. C.M. O'Connor, W.A. Gattis, B.F. Uretsky, K.F. Adams Jr., S.E. McNulty, and S.H. Grossman Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 1999 78 86
65. J.N. Cohn, S.O. Goldstein, B.H. Greenberg, B.H. Lorell, R.C. Bourge, B.E. Jaski Vesnarinone Trial Investigators A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure N Engl J Med 339 1998 1810 1816
66. M. Packer, J.R. Carver, R.J. Rodeheffer, R.J. Ivanhoe, R. DiBianco, S.M. Zeldis PROMISE Study Research Group Effect of oral milrinone on mortality in severe chronic heart failure N Engl J Med 325 1991 1468 1475
67. A.J. Cowley, A.M. Skene Enoximone Investigators Treatment of severe heart failure: quantity or quality of life? A trial of enoximone Br Heart J 72 1994 226 230
68. J.R. Teerlink, C.P. Clarke, K.G. Saikali, J.H. Lee, M.M. Chen, and R.D. Escandon Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study Lancet 378 2011 667 675
69. F.I. Malik, J.J. Hartman, K.A. Elias, B.P. Morgan, H. Rodriguez, and K. Brejc Cardiac myosin activation: a potential therapeutic approach for systolic heart failure Science 331 2011 1439 1443
70. J.G. Cleland, J.R. Teerlink, R. Senior, E.M. Nifontov, J.J. McMurray, and C.C. Lang The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial Lancet 378 2011 676 683
71. V. Mitrovic, H. Luss, K. Nitsche, K. Forssmann, E. Maronde, and K. Fricke Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial Am Heart J 150 2005 1239.e2 1239.e8
72. V. Mitrovic, P.M. Seferovic, D. Simeunovic, A.D. Ristic, M. Miric, and V.S. Moiseyev Haemodynamic and clinical effects of ularitide in decompensated heart failure Eur Heart J 27 2006 2823 2832
73. A. Maisel, C. Mueller, R. Nowak, W.F. Peacock, J.W. Landsberg, and P. Ponikowski Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
74. S.U. Rehman, T. Mueller, and J.L. Januzzi Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure J Am Coll Cardiol 52 2008 1458 1465
75. J.L. Januzzi Jr., W.F. Peacock, A.S. Maisel, C.U. Chae, R.L. Jesse, and A.L. Baggish Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol 50 2007 607 613
76. A.S. Maisel, C. Mueller, R. Fitzgerald, R. Brikhan, B.C. Hiestand, and N. Iqbal Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated Heart Failure (GALLANT) trial Eur J Heart Fail 13 2011 846 851
77. K. Shrestha, A.G. Borowski, R.W. Troughton, J.D. Thomas, A.L. Klein, and W.H. Tang Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure J Card Fail 17 2011 472 478
78. T. Breidthardt, T. Socrates, B. Drexler, M. Noveanu, C. Heinisch, and N. Arenja Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure Crit Care 16 2012 R2
79. S.P. Collins, K.W. Hart, C.J. Lindsell, G.J. Fermann, N.L. Weintraub, and K.F. Miller Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events Eur J Heart Fail 14 2012 1020 1029
80. M. Dupont, K. Shrestha, D. Singh, A. Awad, C. Kovach, and M. Scarcipino Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure Eur J Heart Fail 14 2012 597 604
81. A. Maisel, Y. Xue, K. Shah, C. Mueller, R. Nowak, and W.F. Peacock Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study Circ Heart Fail 4 2011 613 620
82. R.V. Shah, A.A. Chen-Tournoux, M.H. Picard, R.R. van Kimmenade, and J.L. Januzzi Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure Eur J Heart Fail 12 2010 826 832
83. R.R. van Kimmenade, J.L. Januzzi Jr., P.T. Ellinor, U.C. Sharma, J.A. Bakker, and A.F. Low Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 2006 1217 1224
84. B. Ky, B. French, W.C. Levy, N.K. Sweitzer, J.C. Fang, and A.H. Wu Multiple biomarkers for risk prediction in chronic heart failure Circ Heart Fail 5 2012 183 190
85. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, C.M. Gibson, S.A. Murphy, and N. Rifai Multimarker approach to risk stratification in nonST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 105 2002 1760 1763
86. S.F. Jencks, M.V. Williams, and E.A. Coleman Rehospitalizations among patients in the Medicare fee-for-service program N Engl J Med 360 2009 1418 1428
87. G.C. Fonarow, C.W. Yancy, and J.T. Heywood Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE registry Arch Intern Med 165 2005 1469 1477
88. P.A. Heidenreich, A. Sahay, J.R. Kapoor, M.X. Pham, and B. Massie Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs Health Care System 2002 to 2006 J Am Coll Cardiol 56 2010 362 368
89. E.Z. Gorodeski, R.C. Starling, and E.H. Blackstone Are all readmissions bad readmissions? N Engl J Med 363 2010 297 298
90. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.G. Stough, M. Gheorghiade, and B.H. Greenberg Association between performance measures and clinical outcomes for patients hospitalized with heart failure JAMA 297 2007 61 70
91. M.E. Patterson, A.F. Hernandez, B.G. Hammill, G.C. Fonarow, E.D. Peterson, and K.A. Schulman Process of care performance measures and long-term outcomes in patients hospitalized with heart failure Med Care 48 2010 210 216
92. A.F. Hernandez, G.C. Fonarow, L. Liang, P.A. Heidenreich, C. Yancy, and E.D. Peterson The need for multiple measures of hospital quality: results from the Get With the Guidelines-Heart Failure Registry of the American Heart Association Circulation 124 2011 712 719
93. P.A. Heidenreich, A.F. Hernandez, C.W. Yancy, L. Liang, E.D. Peterson, and G.C. Fonarow Get With the Guidelines program participation, process of care, and outcome for medicare patients hospitalized with heart failure Circ Cardiovasc Qual Outcomes 5 2012 37 43
94. L.O. Hansen, R.S. Young, K. Hinami, A. Leung, and M.V. Williams Interventions to reduce 30-day rehospitalization: a systematic review Ann Intern Med 155 2011 520 528
95. L.A. Savard, D.R. Thompson, and A.M. Clark A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions Trials 12 2011 194
96. S.I. Chaudhry, J.A. Mattera, J.P. Curtis, J.A. Spertus, J. Herrin, and Z. Lin Telemonitoring in patients with heart failure N Engl J Med 363 2010 2301 2309
97. R.O. Bonow, T.G. Ganiats, C.T. Beam, K. Blake, D.E. Casey Jr., and S.J. Goodlin ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement J Am Coll Cardiol 59 2012 1812 1832
98. A. Mudge, C. Denaro, I. Scott, C. Bennett, A. Hickey, and M.A. Jones The paradox of readmission: effect of a quality improvement program in hospitalized patients with heart failure J Hosp Med 5 2010 148 153
99. T. Jaarsma, M.H. van der Wal, I. Lesman-Leegte, M.L. Luttik, J. Hogenhuis, and N.J. Veeger Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Arch Intern Med 168 2008 316 324
100. F.A. McAlister, S. Stewart, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819
101. D.J. Whellan, V. Hasselblad, E. Peterson, C.M. O'Connor, and K.A. Schulman Metaanalysis and review of heart failure disease management randomized controlled clinical trials Am Heart J 149 2005 722 729
102. A.F. Hernandez, M.A. Greiner, G.C. Fonarow, B.G. Hammill, P.A. Heidenreich, and C.W. Yancy Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure JAMA 303 2010 1716 1722
103. M. Gheorghiade, and E.D. Peterson Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes JAMA 305 2011 2456 2457
104. A.M. Epstein, A.K. Jha, and E.J. Orav The relationship between hospital admission rates and rehospitalizations N Engl J Med 365 2011 2287 2295
105. E.H. Bradley, L. Curry, L.I. Horwitz, H. Sipsma, J.W. Thompson, and M. Elma Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study J Am Coll Cardiol 60 2012 607 614
106. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.G. Stough, M. Gheorghiade, and B.H. Greenberg Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF Arch Intern Med 168 2008 847 854
107. M.A. Secko, J.M. Lazar, L.A. Salciccioli, and M.B. Stone Can junior emergency physicians use E-point septal separation to accurately estimate left ventricular function in acutely dyspneic patients? Acad Emerg Med 18 2011 1223 1226
108. P. Nazerian, S. Vanni, M. Zanobetti, G. Polidori, G. Pepe, and R. Federico Diagnostic accuracy of emergency Doppler echocardiography for identification of acute left ventricular heart failure in patients with acute dyspnea: comparison with Boston criteria and N-terminal prohormone brain natriuretic peptide Acad Emerg Med 17 2010 18 26
109. G. Volpicelli, V. Caramello, L. Cardinale, A. Mussa, F. Bar, and M.F. Frascisco Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure Am J Emerg Med 26 2008 585 591
110. S.A. Kamath, M.H. Drazner, G. Tasissa, J.G. Rogers, L.W. Stevenson, and C.W. Yancy Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the Bioimpedance Cardiography (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial Am Heart J 158 2009 217 223
111. Y. Tanino, J. Shite, O.L. Paredes, T. Shinke, D. Ogasawara, and T. Sawada Whole body bioimpedance monitoring for outpatient chronic heart failure follow up Circ J 73 2009 1074 1079
112. D.J. Wang, and S.S. Gottlieb Impedance cardiography: more questions than answers Curr Cardiol Rep 8 2006 180 186
113. A. Piccoli, M. Codognotto, V. Cianci, G. Vettore, M. Zaninotto, and M. Plebani Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA) J Card Fail 18 2012 226 232
114. A.L. Baggish, U. Siebert, J.G. Lainchbury, R. Cameron, S. Anwaruddin, and A. Chen A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score Am Heart J 151 2006 48 54
115. B. Steinhart, K.E. Thorpe, A.M. Bayoumi, G. Moe, J.L. Januzzi Jr., and C.D. Mazer Improving the diagnosis of acute heart failure using a validated prediction model J Am Coll Cardiol 54 2009 1515 1521
116. A.S. Maisel, W.F. Peacock, N. McMullin, R. Jessie, G.C. Fonarow, and J. Wynne Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis J Am Coll Cardiol 52 2008 534 540
117. R.L. West, A.F. Hernandez, C.M. O'Connor, R.C. Starling, and R.M. Califf A review of dyspnea in acute heart failure syndromes Am Heart J 160 2010 209 214
118. G.M. Felker, P.S. Pang, K.F. Adams, J.G. Cleland, G. Cotter, and K. Dickstein Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Fail 3 2010 314 325
119. M. Metra, G.M. Felker, V. Zaca, S. Bugatti, C. Lombardi, and L. Bettari Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy Int J Cardiol 144 2010 175 179
120. D.E. Forman, J. Butler, Y. Wang, W.T. Abraham, C.M. O'Connor, and S.S. Gottlieb Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67
121. L. Klein, B.M. Massie, J.D. Leimberger, C.M. O'Connor, I.L. Pina, and K.F. Adams Jr. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Circ Heart Fail 1 2008 25 33
122. M. Metra, S. Nodari, G. Parrinello, T. Bordonali, S. Bugatti, and R. Danesi Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance Eur J Heart Fail 10 2008 188 195
123. W. Mullens, Z. Abrahams, G.S. Francis, G. Sokos, D.O. Taylor, and R.C. Starling Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
124. K. Damman, V.M. van Deursen, G. Navis, A.A. Voors, D.J. van Veldhuisen, and H.L. Hillege Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease J Am Coll Cardiol 53 2009 582 588
125. C. Fallick, P.A. Sobotka, and M.E. Dunlap Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation Circ Heart Fail 4 2011 669 675
126. J.E. Blair, P.S. Pang, R.W. Schrier, M. Metra, B. Traver, and T. Cook Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial Eur Heart J 32 2011 2563 2572
127. J.E. Udelson Heart failure with preserved ejection fraction Circulation 124 2011 e540 e543
128. G.C. Fonarow, W.G. Stough, W.T. Abraham, N.M. Albert, M. Gheorghiade, and B.H. Greenberg Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
129. M.R. Zile, W.H. Gaasch, I.S. Anand, M. Haass, W.C. Little, and A.B. Miller Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial Circulation 121 2010 1393 1405
130. G.M. Felker, J.D. Leimberger, R.M. Califf, M.S. Cuffe, B.M. Massie, and K.F. Adams Jr. Risk stratification after hospitalization for decompensated heart failure J Card Fail 10 2004 460 466
131. C.M. O'Connor, W.T. Abraham, N.M. Albert, R. Clare, W. Gattis Stough, and M. Gheorghiade Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Am Heart J 156 2008 662 673
132. C.M. O'Connor, V. Hasselblad, R.H. Mehta, G. Tasissa, R.M. Califf, and M. Fiuzat Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score J Am Coll Cardiol 55 2010 872 878
133. P.N. Peterson, J.S. Rumsfeld, L. Liang, N.M. Albert, A.F. Hernandez, and E.D. Peterson A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association Get With the Guidelines program Circ Cardiovasc Qual Outcomes 3 2010 25 32
134. M. Hsieh, T.E. Auble, and D.M. Yealy Validation of the Acute Heart Failure Index Ann Emerg Med 51 2008 37 44
135. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, and A.B. Cropp The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
136. K.D. Aaronson, J.S. Schwartz, T.M. Chen, K.L. Wong, J.E. Goin, and D.M. Mancini Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
137. A. Goda, P. Williams, D. Mancini, and L.H. Lund Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM) J Heart Lung Transpl 30 2011 1236 1243
138. L.A. Allen, M. Gheorghiade, K.J. Reid, S.M. Dunlay, P.S. Chan, and P.J. Hauptman Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life Circ Cardiovasc Qual Outcomes 4 2011 389 398
139. M. Metra, J.R. Teerlink, G.M. Felker, B.H. Greenberg, G. Filippatos, and P. Ponikowski Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study Eur J Heart Fail 12 2010 1130 1139
140. M. Metra, C.M. O'Connor, B.A. Davison, J.G. Cleland, P. Ponikowski, and J.R. Teerlink Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study Eur Heart J 32 2011 1519 1534
141. J.A. Ezekowitz, A.F. Hernandez, C.M. O'Connor, R.C. Starling, G. Proulx, and M.H. Weiss Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow J Am Coll Cardiol 59 2012 1441 1448
142. L.A. Allen, A.F. Hernandez, C.M. O'Connor, and G.M. Felker End points for clinical trials in acute heart failure syndromes J Am Coll Cardiol 53 2009 2248 2258
143. M. Gheorghiade, and F. Ruschitzka Beyond dyspnoea as an endpoint in acute heart failure trials Eur Heart J 32 2011 1442 1445
144. J.R. Teerlink Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure Am Heart J 145 2003 S26 S33
145. M. Packer, W.T. Abraham, M.R. Mehra, C.W. Yancy, C.E. Lawless, and J.E. Mitchell Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure J Am Coll Cardiol 47 2006 2245 2252
146. V.M. Conraads, L. Tavazzi, M. Santini, F. Oliva, B. Gerritse, and C.M. Yu Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial Eur Heart J 32 2011 2266 2273
147. D.J. van Veldhuisen, F. Braunschweig, V. Conraads, I. Ford, M.R. Cowie, and G. Jondeau Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure Circulation 124 2011 1719 1726
148. D.J. Whellan, K.T. Ousdigian, S.M. Al-Khatib, W. Pu, S. Sarkar, and C.B. Porter Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study J Am Coll Cardiol 55 2010 1803 1810
149. J. Ritzema, R. Troughton, I. Melton, I. Crozier, R. Doughty, and H. Krum Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure Circulation 121 2010 1086 1095
150. G.V. Sharma, P.A. Woods, N. Lindsey, C. O'Connell, L. Connolly, and J. Joseph Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial J Card Fail 17 2011 718 725
151. M.M. Givertz Hemodynamic monitoring to guide treatment of acute heart failure J Card Fail 17 2011 726 728
152. J.L. Januzzi Jr., S.U. Rehman, A.A. Mohammed, A. Bhardwaj, L. Barajas, and J. Barajas Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
153. S.M. Bernheim, J.N. Grady, Z. Lin, Y. Wang, Y. Wang, and S.V. Savage National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release Circ Cardiovasc Qual Outcomes 3 2010 459 467
154. A.B. Storrow, S.P. Collins, M.S. Lyons, L.E. Wagoner, W.B. Gibler, and C.J. Lindsell Emergency department observation of heart failure: preliminary analysis of safety and cost Congest Heart Fail 11 2005 68 72
155. I.C. Rokos, W.J. French, W.J. Koenig, S.J. Stratton, B. Nighswonger, and B. Strunk Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-balloon times across 10 independent regions JACC Cardiovasc Interv 2 2009 339 346
156. P.S. Keenan, S.L. Normand, Z. Lin, E.E. Drye, K.R. Bhat, and J.S. Ross An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure Circ Cardiovasc Qual Outcomes 1 2008 29 37
157. E.F. Philbin, and T.G. DiSalvo Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data J Am Coll Cardiol 33 1999 1560 1566
158. R.J. Petrucci, L.A. Benish, B.L. Carrow, L. Prato, S.R. Hankins, and H.J. Eisen Ethical considerations for ventricular assist device support: a 10-point model ASAIO J 57 2011 268 273
159. J.W. Entwistle, R.M. Sade, and R.J. Petrucci The ethics of mechanical support: the need for new guidelines Ann Thorac Surg 92 2011 1939 1942
160. S.J. Goodlin Palliative care in congestive heart failure J Am Coll Cardiol 54 2009 386 396
161. L.S. Evangelista, D. Lombardo, S. Malik, J. Ballard-Hernandez, M. Motie, and S. Liao Examining the effects of an outpatient palliative care consultation on symptom burden, depression, and quality of life in patients with symptomatic heart failure J Card Fail 18 2012 894 899
162. M. Gheorghiade, M. Albaghdadi, F. Zannad, G.C. Fonarow, M. Bohm, and C. Gimpelewicz Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) Eur J Heart Fail 13 2011 100 106
163. M. Gheorghiade, M. Bohm, S.J. Greene, G.C. Fonarow, E.F. Lewis, and F. Zannad Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial JAMA 309 2013 1125 1135